Catalent, Inc., a global leader in drug development and manufacturing solutions, has announced its plans to revolutionize the industry by catering to a wide range of products, including prescription drugs, over-the-counter medications, dietary supplements, cosmetics, and animal health medicinal preparations. With subsidiaries specializing in Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services, the company aims to provide formulation, development, and manufacturing services across various technologies. Additionally, Catalent's FlexDirect and FastChain services offer direct-to-patient and demand-led clinical supply solutions, respectively. Headquartered in Somerset, New Jersey, the company serves pharmaceutical, biotechnology, consumer health, medical devices, and cosmetics industries.